Success Metrics

Clinical Success Rate
81.0%

Based on 17 completed trials

Completion Rate
81%(17/21)
Active Trials
2(8%)
Results Posted
18%(3 trials)
Terminated
4(16%)

Phase Distribution

Ph phase_1
3
12%
Ph phase_2
11
44%
Ph phase_3
5
20%
Ph phase_4
5
20%

Phase Distribution

3

Early Stage

11

Mid Stage

10

Late Stage

Phase Distribution24 total trials
Phase 1Safety & dosage
3(12.5%)
Phase 2Efficacy & side effects
11(45.8%)
Phase 3Large-scale testing
5(20.8%)
Phase 4Post-market surveillance
5(20.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.0%

17 of 21 finished

Non-Completion Rate

19.0%

4 ended early

Currently Active

2

trials recruiting

Total Trials

25

all time

Status Distribution
Active(2)
Completed(17)
Terminated(4)
Other(2)

Detailed Status

Completed17
Terminated4
Recruiting2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
25
Active
2
Success Rate
81.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (12.5%)
Phase 211 (45.8%)
Phase 35 (20.8%)
Phase 45 (20.8%)

Trials by Status

terminated416%
recruiting28%
completed1768%
unknown28%

Recent Activity

Clinical Trials (25)

Showing 20 of 25 trialsScroll for more
NCT07169695Phase 2

A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis

Recruiting
NCT00809172Phase 3

Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients

Completed
NCT05996393Phase 4

CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly

Completed
NCT00866684Phase 4

Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

Terminated
NCT05155007Phase 1

A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir

Completed
NCT06004752Phase 2

Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly

Unknown
NCT06009497Phase 4

Romiplostim in Combination With CsA vs. CsA in the Treatment of Newly Diagnosed NSAA

Unknown
NCT05674695

Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy

Recruiting
NCT00773292Phase 2

Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)

Completed
NCT03466567Phase 1

A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects

Completed
NCT02390674Phase 2

Ciclosporin to Reduce Reperfusion Injury in Primary PCI

Completed
NCT01968057Phase 1

A Study of Baricitinib and Ciclosporin in Healthy Participants

Completed
NCT02366585Phase 2

The Effect of Locally Delivered Ciclosporin as an Adjunct to Healing After Treatment of Periodontal Pockets

Completed
NCT02397213Phase 2

Ciclosporin to Protect Renal Function In Cardiac Surgery

Completed
NCT00919776Phase 2

Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum

Completed
NCT00919451Phase 2

Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy

Completed
NCT00919815Phase 2

Ciclosporin in the Management of New Type 1 Reactions in Leprosy

Completed
NCT00919542Phase 2

Ciclosporin in the Management of New Erythema Nodosum Leprosum

Completed
NCT00916045Phase 2

Pilot Study of Unrelated Cord Blood Transplantation

Terminated
NCT01231854Phase 4

Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
25